Greenspace Labs was founded to address the lack of clinical evidence and standardization for cannabinoid-based medicine. There have been incredible claims related to the efficacy of cannabis, CBD, and other cannabinoids for a whole range of diseases, but most lack the science to back up those statements.

To date, there has been only one Food and Drug Administration (FDA) approved cannabinoid-based treatment, a CBD containing oil to treat pediatric epilepsy. Greenspace is working with the FDA to bring other treatments to market by following the appropriate regulatory pathways and conducting the necessary clinical studies.